McAdam LLC’s Teladoc Health TDOC Stock Holding History

McAdam LLC’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-69	Closed	-$6K	–	542
2018 Q3	$6K	Hold	69	–	–	﹤0.01%	397
2018 Q2	$4K	Hold	69	–	–	﹤0.01%	435
2018 Q1	$3K	Buy	+69	New	+$2.6K	﹤0.01%	488

Other funds holding TDOC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ZCI

Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

McAdam LLC's TDOC Position: Q4 2018 in Review

McAdam LLC sold out of Teladoc Health (TDOC) in Q4 2018, closing a stake of 69 shares — an estimated $6K sold.

McAdam LLC first reported a position in TDOC in Q1 2018 and held it in 3 quarters. The position peaked at $6K in Q3 2018. 326 funds tracked by Wall St. Rank hold TDOC as of Q4 2018.

McAdam LLC reported no remaining Teladoc Health position as of Q4 2018 after selling out during the quarter.
McAdam LLC sold 69 Teladoc Health shares in Q4 2018, an estimated $6K.
McAdam LLC first reported a position in Teladoc Health in Q1 2018 and held it in 3 quarters.
McAdam LLC's Teladoc Health position peaked at $6K in Q3 2018.
326 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2018.

Based on McAdam LLC's 13F filing for Q4 2018, filed 30 Jan 2019.